Evaluation of a novel software application for magnetic resonance distortion correction in cranial stereotactic radiosurgery

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Calvo-Ortega JF
  • Mateos J
  • Moragues S
  • Acebes JJ
  • San Jose, S
  • Casals J

Grupos

Abstract

This study aimed to validate a novel commercially available software for correcting spatial distortion in cranial magnetic resonance (MR) images. This software has been used to assess the dosimetric impact of MR distortion in stereotactic radiosurgery (SRS) treatments of vestibular schwannomas (VSs). Five MR datasets were intentionally distorted. Each distorted MR dataset was corrected using the Cranial Distortion software, obtaining a new corrected MR dataset (MRcorr). The accuracy of the correction was quantified by calculating the target registration error (TRE) for 6 anatomical landmarks identified in the co-registered MRcorr and planning computed tomography (pCT) images. Nine VS cases were included to investigate the impact of the MR distortion in SRS plans. Each SRS plan was calculated on the pCT (1 x 1 x 1 mm(3) voxel) with the target and organs at risk (OARs) delineated using the planning MR dataset. This MR dataset was then corrected (MRcorr) using the Cranial Distortion software. Geometrical agreement between the original target and the corresponding corrected target was assessed using several metrics: MacDonald criteria, mean distance to agreement (MDA), and Dice similarity coefficient (DSC). Target coverage (D99%) and maximum doses (D2%) to ipsilateral cochlea and brainstem resulting on the MRcorr dataset were compared with the original values. TRE values (0.6 mm +/- 0.3 mm) and differences found in Macdonald criteria (0.3 mm +/- 0.4 mm and 0.3 mm +/- 1 0.3 mm) and MDA (0.8 mm +/- 0.2 mm) were mostly within the voxel size dimension of the pCT scan (1 x 1 x 1 mm(3)). High similarity (DSC > 0.7) between the original and corrected targets was found. Small dose differences for the original and corrected structures were found: 0.1 Gy +/- 0.1 Gy for target D99%, 0.2 Gy +/- 10.3 Gy for cochlea D2%, and 0.1 Gy +/- 0.1 Gy for brainstem D2%. Our study shows that Distortion Correction software can be a helpful tool to detect and adequately correct brain MR distortions. However, a negligible dosimetric impact of MR distortion has been detected in our clinical practice. (C) 2018 American Association of Medical Dosimetrists. Published by Elsevier B.V. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0958-3947, 1873-4022

MEDICAL DOSIMETRY  ELSEVIER SCIENCE INC

Tipo:
Article
Páginas:
136-143
PubMed:
29752157
Factor de Impacto:
0,623 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 2

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Distortion; MR; SRS

Proyectos y Estudios Clínicos

PATRONES DE RM CEREBRAL Y MEDULAR EN RELACION CON LA PRESENCIA DE AUTOANTIGENOS NEURONALES RECONOCIDOS POR INMUNOGLOBULINAS M PRESENTES EN EL LIQUIDO CEFALORRAQUIDEO DE PACIENTES DE ESCLEROSIS MULTIPLE.

Investigador Principal: ISABEL BOSCÁ BLASCO

MERCK SERONO DR. CASANOVA . ALMIRALL S.A; FUNDACIÓN BIOGEN IDEC; MERCK S.L.U; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2010

CONTROL Y SEGUIMIENTO INTEGRAL DE LA RADIACIÓN IONIZANTE RECIBIDA TRAS EXPLORACIONES MÉDICAS: COSIRI.

Investigador Principal: ÁNGEL ALBERICH BAYARRI

GV/2015/132 . FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA; CONSELLERIA DE EDUCACION . 2015

PREMICAT. DESARROLO DE UNA ESTRATEGIA PARA LA PREVENCION MIOCARDICA DEL DAÑO INDUCIDO POR REPERFUSION BASADA EN EL USO DE CATETERES Y POLIMEROS TARAPEUTICOS DE NUEVA GENERACION.

Investigador Principal: PILAR SEPÚLVEDA SANCHIS

DTS15/00079 . INSTITUTO DE SALUD CARLOS III . 2016

TERAPIA CELULAR DESPUES DEL ICTUS DIRIGIDA MEDIANTE CAMPOS MAGNETICOS. APLICACION DE RM-TDI Y TRACTOGRAFIA CEREBRAL EN ICTUS PARA LA VALORACION DEL DAÑO NEUROLOGICO

Investigador Principal: JOSÉ MANUEL GARCÍA VERDUGO

2015_0534_GARCIA_VERDUGO_MAPFRE . 2015

DISEÑO Y DESARROLLO DE UNA PLATAFORMA MULTIESCALA-IN VITRO-IN VIVO PARA LA PREVENCIÓN DE LA FRACTURA ÓSEA OSTEOPORÓTICA MEDIANTE CEMENTACIÓN FEMORAL: UNA HERRAMIENTA PRECLÍNICA

Investigador Principal: ÁNGEL ALBERICH BAYARRI

DPI2014-53401-C2-2-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015

Ingeniería de Tejidos para Mieloma Múltiple.

Investigador Principal: ÁNGEL ALBERICH BAYARRI

DPI2017-84780-C2-2-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2018

Cita

Compartir